Diagnostic Performance of Noninvasive Biomarkers for Early Detection of Preeclampsia: A Systematic Review
Journal of Nature and Science of Medicine · 2026-04 · 9 (2) · 176-192
DOI: 10.4103/jnsm.jnsm_320_25 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Nature and Science of Medicine, online erschienen am 30.04.2026. Verfasst von Ali Bassi und 10 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Preeclampsia (PE) remains a major cause of maternal and perinatal morbidity, and reliable early prediction is essential for timely prevention. Numerous noninvasive biomarkers have been proposed, but their comparative performance in early pregnancy is not consistently established.
Objective
To evaluate the diagnostic accuracy of noninvasive biomarkers measured before 20 weeks’ gestation for the prediction of PE and to identify core markers with the strongest and most consistent predictive contribution. Materials and Methods: A systematic review of studies assessing biochemical, molecular, and biophysical biomarkers in early pregnancy was conducted. Data on study characteristics and predictive performance were extracted. Pooled estimates and subgroup analyses were performed where appropriate.
Results
Multimarker models integrating clinical and biochemical measures demonstrated higher accuracy than single biomarkers (pooled area under the receiver operating characteristic curve: 0.89; sensitivity: 0.86; and specificity: 0.89). Placental growth factor (PlGF) showed the strongest independent association with subsequent PE (pooled adjusted odds ratio [aOR]: 3.5 and 95% confidence interval [CI]: 2.8–4.4), followed by mean arterial pressure (MAP) (aOR: 2.8, 95% CI: 2.2–3.6). Uterine artery pulsatility index contributed additional but more modest predictive value (aOR 2.1, 95% CI 1.7–2.6). Molecular biomarkers demonstrated variable performance across studies.
Conclusion
Early prediction of PE is achievable using a streamlined panel centered on PlGF and MAP, with uterine artery Doppler pulsatility index providing supplemental refinement where feasible. Further validation in diverse populations is needed to support routine clinical implementation.
Zitieren
APA
Bassi, A., Almalki, A., AlShehri, E., Alenezi, F. B., Bokhari, R. Y., Alhawsawi, H. T., Alaqil, N. A., Aljumaiah, D. F., Mulayhi, F. A., Demadi, S. S., & Mulayhi, L. A. (2026). Diagnostic Performance of Noninvasive Biomarkers for Early Detection of Preeclampsia: A Systematic Review. Journal of Nature and Science of Medicine, 9(2), 176-192. https://doi.org/10.4103/jnsm.jnsm_320_25
Vancouver
Bassi A, Almalki A, AlShehri E, Alenezi FB, Bokhari RY, Alhawsawi HT, et al. Diagnostic Performance of Noninvasive Biomarkers for Early Detection of Preeclampsia: A Systematic Review. Journal of Nature and Science of Medicine. 2026;9(2):176-192. doi:10.4103/jnsm.jnsm_320_25
BibTeX
@article{Bassi2026,
author = {Bassi, Ali and Almalki, Ahmad and AlShehri, Eman and Alenezi, Farah Bader and Bokhari, Razan Yaser and Alhawsawi, Hebah Tareq and Alaqil, Nehal Abdurhman and Aljumaiah, Dhuha Fahad and Mulayhi, Fatimah Ahmad and Demadi, Seham Saeed and Mulayhi, Laila Ahmad},
title = {Diagnostic Performance of Noninvasive Biomarkers for Early Detection of Preeclampsia: A Systematic Review},
journal = {Journal of Nature and Science of Medicine},
year = {2026},
volume = {9},
number = {2},
pages = {176--192},
doi = {10.4103/jnsm.jnsm_320_25}
}
EUVIMED